CanSino Biologics Inc (CJH) — Cash Flow-to-Debt Ratio
CanSino Biologics Inc (CJH) has a Cash Flow-to-Debt Ratio of -0.10x as of June 2023, meaning its operating cash flow of €-392.00 Million could theoretically repay 0% of its total liabilities (€3.93 Billion) in one year. Check CanSino Biologics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CanSino Biologics Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for CanSino Biologics Inc across 10 annual periods. Also explore CJH total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for CanSino Biologics Inc (2016–2025)
Year-by-year debt coverage analysis for CanSino Biologics Inc. For market capitalisation and broader financial context, see CanSino Biologics Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | €77.86 Million | €2.22 Billion | ▲ +163.2% |
| 2024 | -0.06x | €-168.79 Million | €3.05 Billion | ▲ +75.6% |
| 2023 | -0.23x | €-916.25 Million | €4.03 Billion | ▲ +48.2% |
| 2022 | -0.44x | €-1.85 Billion | €4.22 Billion | ▼ -171.1% |
| 2021 | 0.62x | €2.05 Billion | €3.33 Billion | ▲ +219.3% |
| 2020 | -0.52x | €-349.93 Million | €677.22 Million | ▼ -5.2% |
| 2019 | -0.49x | €-154.25 Million | €313.98 Million | ▼ -16.6% |
| 2018 | -0.42x | €-123.64 Million | €293.56 Million | ▼ -93.8% |
| 2017 | -0.22x | €-56.30 Million | €259.03 Million | ▲ +29.4% |
| 2016 | -0.31x | €-34.38 Million | €111.70 Million | — |